CN Patent

CN114569617B — 甲基硒酸作为吉非替尼治疗吉非替尼耐药的非小细胞肺癌增敏剂的新用途

Assigned to China Agricultural University · Expires 2022-07-29 · 4y expired

What this patent protects

本发明提供一种甲基硒酸作为吉非替尼治疗吉非替尼耐药的非小细胞肺癌增敏剂的新用途。本发明揭示了甲基硒酸具有增强吉非替尼在吉非替尼耐药的非小细胞肺癌的生长抑制作用，对吉非替尼在抗吉非替尼耐药的非小细胞肺癌方面具有较好的增效作用；本发明为研制以甲基硒酸和吉非替尼为基础的抗吉非替尼耐药的非小细胞肺癌药物提供了科学依据，具有重大的应用价值。

USPTO Abstract

本发明提供一种甲基硒酸作为吉非替尼治疗吉非替尼耐药的非小细胞肺癌增敏剂的新用途。本发明揭示了甲基硒酸具有增强吉非替尼在吉非替尼耐药的非小细胞肺癌的生长抑制作用，对吉非替尼在抗吉非替尼耐药的非小细胞肺癌方面具有较好的增效作用；本发明为研制以甲基硒酸和吉非替尼为基础的抗吉非替尼耐药的非小细胞肺癌药物提供了科学依据，具有重大的应用价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN114569617B
Jurisdiction
CN
Classification
—
Expires
2022-07-29
Drug substance claim
No
Drug product claim
No
Assignee
China Agricultural University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.